ClinicalTrials.gov
ClinicalTrials.gov Menu

Efficacy and Safety Study of Intranasal Administration of 100, 200, and 400 μg of Fluticasone Propionate

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01624662
Recruitment Status : Completed
First Posted : June 21, 2012
Last Update Posted : September 27, 2016
Sponsor:
Information provided by (Responsible Party):
Optinose US Inc.

Results Submitted - Not Posted on ClinicalTrials.gov
Results information has been submitted to ClinicalTrials.gov by the sponsor or investigator, but is not yet publicly available (or "posted") on ClinicalTrials.gov. The submitted information may not be available if it is pending Quality Control (QC) Review by the National Library of Medicine (NLM) or if issues identified during QC review are being addressed or corrected by the sponsor or investigator. NLM's limited QC review assesses for apparent errors, deficiencies, or inconsistencies. NLM staff do not verify the scientific validity or relevance of the submitted information.
  Recruitment Status : Completed
  Actual Primary Completion Date : August 2015
  Actual Study Completion Date : October 2015
  Certification/Extension First Submitted : July 21, 2016

Submission Cycle Results Submitted to ClinicalTrials.gov Results Returned after Quality Control Review
1 October 17, 2017 November 17, 2017
2 November 29, 2017  
3 December 20, 2017 January 19, 2018
4 January 23, 2018 February 20, 2018